> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA/Pharmacy Boards MOU for Compounded Drugs
- URL: https://www.fdaweb.com/fda-pharmacy-boards-mou-for-compounded-drugs/
- Published: 2020-10-26T12:00:00.000Z
- Updated: 2026-09-14T16:33:58.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147952

*Federal Register* notice: FDA has made available a final standard memorandum of understanding (MOU) entitled “Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products Between the \[insert State Board of Pharmacy or Other Appropriate State Agency\] and the U.S. Food and Drug Administration.” The MOU describes the responsibilities of a state board of pharmacy or other appropriate state agency in investigating and responding to complaints related to drug products compounded in their state. It also discusses responsibilities when compounded products are distributed outside the state, and when there is interstate distribution of inordinate product amounts. To view the notice, click [here](https://public-inspection.federalregister.gov/2020-23687.pdf?ref=fdaweb.com).